Direct Isolation of Treponema pallidum from Syphilis Patients
从梅毒患者中直接分离梅毒螺旋体
基本信息
- 批准号:10511750
- 负责人:
- 金额:$ 23.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-23 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAntimicrobial ResistanceAntimicrobial susceptibilityAzithromycinBacteriaBiological AvailabilityBiologyBloodBody FluidsCharacteristicsClinicalCoculture TechniquesCollectionCommunitiesCongenital SyphilisDevelopmentDiseaseEpithelial CellsGene Expression ProfileGeneticGenomicsGlobus PallidusGoalsGrowthHistopathologyIn VitroInfantInfectionLaboratory cultureLatent SyphilisLeadLengthLesionMethodsModelingModernizationMorphologyOrder SpirochaetalesOrganismOryctolagus cuniculusPathogenesisPatient-Focused OutcomesPatientsPatternPhenotypePhysiologicalPlacentaPredispositionPrimary LesionPropertyResearchResearch PersonnelSamplingSecondary LesionSequence AnalysisSexually Transmitted DiseasesSpecimenSyphilisSyphilitic chancreSystemTemperatureTestingTestisTissuesTreponema pallidumTubeUmbilical cord structureVariantVirulenceantimicrobial drugclinical research siteexperimental studygenetic analysishuman pathogenin vivoinsightnovelskin lesiontissue tropism
项目摘要
Research on Treponema pallidum subspecies pallidum (T. pallidum), the causative agent of syphilis, was impeded for years by inability to cultivate the spirochete in vitro. This limitation also hampered isolation of new
T. pallidum strains with the result that most research strains were isolated in the last century and have been propagated in rabbits for many years. In 2018, we developed an in vitro culture system involving co-culture of T. pallidum with Sf1Ep rabbit epithelial cells under microaerobic conditions that has resulted in continuous in vitro cultivation of T. pallidum. Currently, we have maintained cultures in vitro for over three years, and these cultures have retained full virulence in the rabbit model. Here, we propose to use this newly developed in vitro system to isolate novel strains of T. pallidum directly from clinical samples derived from syphilis patients. In the Aim 1, we will attempt to isolate new strains of T. pallidum from patients. Initial experiments will focus on the best approaches to collect samples and maintain T. pallidum viability during transport from clinical sites. After definition of these parameters, we will proceed with isolation of T. pal/idum from patient lesions and from placenta and umbilical cord specimens from infants with suspected congenital syphilis. Our clinical co-investigators will coordinate collection of patient samples and we will use the in vitro culture system to expand those samples in vitro. In Aim 2, the new patient-derived T. pallidum strains will be analyzed for differences in in vitro growth rates and infection properties in the rabbit model (e.g. in vivo growth rates, dissemination, tissue tropism, and histopathology). Antimicrobial susceptibility will also be examined using a well-developed in vitro culture procedure. Lastly, genomic sequencing will be performed to permit analysis of the sequences of the isolated strains for differences related to their physiologic and infection properties, particularly in view of their relationship to the ongoing changes in the distribution of the Nichols and SS14 genetic clusters and of azithromycin susceptibility. It is anticipated that this project will lead to greatly increased efficiency of T. pallidum isolation relative to rabbit inoculation, thereby permitting a much more thorough characterization of strains causing this important sexually transmitted infection. Analyses of variability present in modern syphilis strains can lead to insight into community infection patterns, patient outcomes, and the development of antimicrobial resistance in the community. In addition, successful completion of this project will also allow for the creation of a readily available bank of syphilis strains for research, greatly increasing the number of strains that are available for the physiologic and genetic analysis of this important human pathogen.
梅毒螺旋体(Treponema pallidum, T. pallidum)是梅毒的病原体,由于无法在体外培养螺旋体,对其亚种梅毒螺旋体的研究一直受到阻碍。这一限制也阻碍了新技术的分离
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diane G Edmondson其他文献
Diane G Edmondson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diane G Edmondson', 18)}}的其他基金
Direct Isolation of Treponema pallidum from Syphilis Patients
从梅毒患者中直接分离梅毒螺旋体
- 批准号:
10652662 - 财政年份:2022
- 资助金额:
$ 23.4万 - 项目类别:
Factors Affecting longterm in vitro culture of Treponema pallidum
梅毒螺旋体长期体外培养的影响因素
- 批准号:
10226897 - 财政年份:2018
- 资助金额:
$ 23.4万 - 项目类别:
Factors Affecting longterm in vitro culture of Treponema pallidum
梅毒螺旋体长期体外培养的影响因素
- 批准号:
10000844 - 财政年份:2018
- 资助金额:
$ 23.4万 - 项目类别:
相似海外基金
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响
- 批准号:
BB/Y003861/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
Engineering Nature-based Solutions to Tackle Antimicrobial Resistance
工程基于自然的解决方案来解决抗菌素耐药性
- 批准号:
EP/Y003101/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
The epidemiology of transmissible antimicrobial resistance among Shigella species
志贺菌属中传播性抗菌药物耐药性的流行病学
- 批准号:
MR/X000648/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
Active one health surveillance in LMICs to monitor and predict Antimicrobial Resistance Using Metagenomics (ALARUM)
在中低收入国家中开展主动单一健康监测,利用宏基因组学 (ALARUM) 监测和预测抗菌药物耐药性
- 批准号:
MR/Y034287/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
A novel anti-biofilm peptide from fish for the combat against antimicrobial resistance
一种来自鱼类的新型抗生物膜肽,用于对抗抗菌素耐药性
- 批准号:
MR/Y503393/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome.
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响。
- 批准号:
BB/Y004108/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
A Cell-Free Toolbox to Anticipate, Learn and Counter Antimicrobial Resistance
预测、学习和对抗抗菌素耐药性的无细胞工具箱
- 批准号:
BB/Y005074/1 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Research Grant
Roles of emerging pollutants in spreading antimicrobial resistance
新出现的污染物在传播抗菌素耐药性方面的作用
- 批准号:
DE240100842 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别:
Discovery Early Career Researcher Award
Environmental Reservoirs and Antimicrobial Resistance in Non-tuberculosis Mycobacteria: A Genomic Investigation
非结核分枝杆菌的环境储库和抗菌素耐药性:基因组研究
- 批准号:
502471 - 财政年份:2024
- 资助金额:
$ 23.4万 - 项目类别: